Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 12:7:100178.
doi: 10.1016/j.rcsop.2022.100178. eCollection 2022 Sep.

Factors associated with medication non-adherence among patients with severe mental disorder - A cross sectional study in a tertiary care centre

Affiliations

Factors associated with medication non-adherence among patients with severe mental disorder - A cross sectional study in a tertiary care centre

Papiya Ghosh et al. Explor Res Clin Soc Pharm. .

Abstract

Background: Medications are an essential treatment modality of mental disorders. There is limited scientific literature on medication non-adherence among patients in Severe Mental Disorders with respect to patient-related factors. The current study explores the factors associated with medication non-adherence in such patients. Objectives: To study the relationship between socio-demographic, clinical, treatment related factors, self-stigma, patients' & caregivers' attitude towards psychotropic medications, doctor-patient communication and medication non-adherence in patients with severe mental disorders.

Methods: A cross-sectional observation study, where patients with severe mental disorders attending Psychiatry Outpatient services, and their caregivers, were recruited. Sociodemographic and clinical variables were recorded using data collection form and illness-specific severity scales. Patients were administered Medication adherence rating scale (MARS), Internalised stigma of mental illness inventory (ISMI- 9), Attitude of patients towards psychotropic medication scale and Doctor-patient communication questionnaire (DPCQ). The Attitude of caregivers towards psychotropic medication scale was administered for caregivers.

Results: Among 152 patients, 58 (38.16%) patients had a diagnosis of schizophrenia, 11 (7.24%) had delusional disorder, 32 (21.05%) patients were diagnosed with bipolar disorder type 1 - mania and 19 (12.50) with bipolar disorder type 2 - depression whereas 32 (21.05%) had major depressive disorder. Majority of the patients were non-adherent to medications (88.16%). MARS score was significantly higher among patients of middle socioeconomic class (p = 0.014), urban domicile (p = 0.033) and those with higher caregivers' age (p = 0.019) . Among 79.61% of patients, ISMI-9 score was minimal to mild. Most patients (76.97%) and caregivers (83.55%) had negative attitude towards psychotropic medications. MARS score negatively correlated with BPRS (p = 0.0001*), HAM-D (p = 0.0004*), YMRS (p = 0.0007*), ISMI-9 (p ≤0.0001*) and the attitude of the caregivers towards psychotropic medicationsnegative scale scores (p = 0.003*) . MARS score positively correlated with DPCQ scores (p ≤0.0001*) .

Conclusion: Medication adherence was higher among patients belonging to uppermiddle socioeconomic status, urban domicile and higher caregiver age. Higher severity of illness, self-stigma and negative attitude of patients and caregivers towards psychotropic medications were associated with lower adherence whereas better doctor-patient communication was associated with higher adherence to medications.

Keywords: Attitude; Caregiver; Medication adherence; Mental disorders; Psychotropics; Stigma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Similar articles

Cited by

References

    1. Mathers C. World Health Organization; 2008. The Global Burden of Disease: 2004 Update.
    1. Jimmy B., Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155–159. doi: 10.5001/omj.2011.38. - DOI - PMC - PubMed
    1. Hogarty G.E., Goldberg S.C., Schooler N.R., Ulrich R.F. Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. Arch Gen Psychiatry. 1974;31(5):603–608. doi: 10.1001/archpsyc.1974.01760170005001. - DOI - PubMed
    1. Julius R.J., Novitsky M.A., Dubin W.R. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract. 2009;15(1):34–44. doi: 10.1097/01.pra.0000344917.43780.77. - DOI - PubMed
    1. Perkins D.O. Adherence to antipsychotic medications. J Clin Psychiatry. 1999;60(21):25–30. - PubMed

LinkOut - more resources